SESophie K. Elvig

Sophie K. Elvig

*This is an algorithmically generated author record based on publicly available information.

Sophie K. Elvig has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Leandro F. Vendruscolo

    Stress and Addiction Neuroscience Unit, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, and National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research, Baltimore, MD, USA

    3 shared publications
  • Corinde E. Wiers

    University of Pennsylvania

    2 shared publications
  • George F. Koob

    Neurobiology of Addiction Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, USA

    2 shared publications
  • Janaina C. M. Vendruscolo

    Neurobiology of Addiction Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, USA

    2 shared publications
  • Nora D. Volkow

    National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, USA

    2 shared publications
  • Steffen B. E. Wolff

    University of Maryland School of Medicine

    2 shared publications

Latest Publications

  • Open Access

    Non-canonical subthalamic nucleus projections regulate motor variability

    by Oluwatomiwa A. Oladunni, Sophie K. Elvig, Hunter C. Bennis, Laila A. Elzaree, Siddhartha Nandy, Yuting Liu, Snigdhansu Chatterjee, Brian N. Mathur, Steffen B.E. Wolff

    Regulation of motor variability is a key hallmark of motor skill learning, balancing motor exploration with optimization of identified task solutions. Nevertheless, the underlying circuit mechanisms in the mammalian brain remain largely unknown. Subnuclei of the dorsal striatum in the basal ganglia promote stereotyped or variable behavior, respectively, and deep brain stimulation of the downstream subthalamic nucleus (STN) can alter motor variability. We therefore tested whether the STN regulates motor variability via non-canonical projections to striatum. We discovered that silencing STN neurons projecting to dorsolateral striatum impaired motor variability reduction in rats developing complex stereotyped movement patterns. In contrast, silencing STN neurons projecting to the anterior thalamic nuclei, or neurons in these nuclei that receive STN input and project to dorsomedial striatum, accelerated variability reduction. These results deepen our anatomical and functional understanding of subcortical motor circuits and reveal unknown roles for STN's non-canonical striatal projections in motor variability regulation.

  • Open Access

    Neurobehavioral effects of focused ultrasound-mediated blood-brain barrier opening

    by Sophie K. Elvig, Alexandra A. Seas, Pavlos Anastasiadis, Steffen B.E. Wolff

    Microbubble-enhanced focused ultrasound (MB-FUS) enables noninvasive blood-brain barrier (BBB) opening to improve the delivery of drugs and other therapeutics to the brain, supporting more effective treatment of brain disorders. The benefits of this rapidly advancing and highly versatile technology have been demonstrated in clinical trials, sparking a growing interest in expanding FUS applications that require higher intensity treatments, larger targeted brain volumes and larger therapeutics. However, in-depth safety profiling of such treatments has not been done and is limited in the clinic. Preclinical studies have been restricted in their readouts, focusing on acute imaging and simple behaviors. To address the need for more holistic safety profiling, we present a novel preclinical workflow for determining adverse effects of MB-FUS in rats, both acutely and long-term, by combining MRI, histology, and a custom motor task which provides fine-scaled readouts for complex learned behavior. Using this approach and taking advantage of our previous delineation of the relevant circuitry, we show dose- and target-dependent adverse effects in high dosing regimens. All prescribed acoustic doses opened the BBB; but while low doses had no overt adverse effects, high doses targeting the involved circuitry had severe effects on both behavior and brain tissue integrity. These effects persisted for weeks and recovered over differing time courses, with tissue disruptions and behavioral changes outlasting general performance deficits. Our results reinforce the need for multimodal, highly sensitive, and longitudinal readouts to holistically characterize adverse effects of MB-FUS, allowing for its safe use across a wide range of applications.

  • Open Access

    A ketogenic diet reduces hepatic alcohol metabolism and alcohol consumption in rats

    by Sophie K. Elvig, Adrienne McGinn, Xinyi Li, Janaina C. M. Vendruscolo, Juan L. Gomez, Robert Pawlosky, Bryan Mackowiak, Luis Gonzalez, M. Todd King, Michael Michaelides, et al.

    Previous work showed that rats that were exposed to a high-fat, low-carbohydrate/protein ketogenic diet (KD) exhibited elevated blood alcohol levels following alcohol exposure compared with rats fed regular chow. Additionally, the administration of a KD prior to alcohol exposure (i.e., a history of KD) reduced alcohol consumption in alcohol-dependent rats that were no longer on the diet. In the present study, we investigated the mechanisms by which a KD alters alcohol metabolism and tested whether ongoing KD exposure reduces alcohol consumption in rats. We hypothesized that chronic KD exposure alters hepatic alcohol-metabolizing enzymes, slows alcohol metabolism, and reduces alcohol self-administration in alcohol-dependent rats. We found that male and female rats maintained on a KD had higher blood alcohol levels, lower hepatic alcohol dehydrogenase 1 protein levels, and a higher nicotinamide adenine dinucleotide [NAD+]/[NADH] ratio in the liver cytoplasm compared with chow-fed control rats. Furthermore, KD-fed rats demonstrated lower brain glucose uptake relative to chow-fed control rats. In a model of alcohol dependence, the KD reduced alcohol consumption in male, but not female, rats compared with chow-fed rats. These findings suggest that a KD alters brain energetics and alcohol metabolism, which may contribute to reduced alcohol consumption in male rats.


  • Top Cited Papers
    Open Access

    The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission

    by Vicky Chuong, Mehdi Farokhnia, Sophia Khom, Claire L. Pince, Sophie K. Elvig, Roman Vlkolinsky, Renata C.N. Marchette, George F. Koob, Marisa Roberto, Leandro F. Vendruscolo, et al.

    Growing evidence indicates that the glucagon-like peptide-1 (GLP-1) system is involved in the neurobiology of addictive behaviors, and GLP-1 analogues may be used for the treatment of alcohol use disorder (AUD). Here, we examined the effects of semaglutide, a long-acting GLP-1 analogue, on biobehavioral correlates of alcohol use in rodents. A drinking-in-the-dark procedure was used to test the effects of semaglutide on binge-like drinking in male and female mice. We also tested the effects of semaglutide on binge-like and dependence-induced alcohol drinking in male and female rats, as well as acute effects of semaglutide on spontaneous inhibitory postsynaptic currents (sIPSCs) from central amygdala (CeA) and infralimbic cortex (ILC) neurons. Semaglutide dose-dependently reduced binge-like alcohol drinking in mice; a similar effect was observed on the intake of other caloric/noncaloric solutions. Semaglutide also reduced binge-like and dependence-induced alcohol drinking in rats. Semaglutide increased sIPSC frequency in CeA and ILC neurons from alcohol-naive rats, suggesting enhanced GABA release, but had no overall effect on GABA transmission in alcohol-dependent rats. In conclusion, the GLP-1 analogue semaglutide decreased alcohol intake across different drinking models and species and modulated central GABA neurotransmission, providing support for clinical testing of semaglutide as a potentially novel pharmacotherapy for AUD.


  • Open Access

    Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents

    by Corinde E. Wiers, Leandro F. Vendruscolo, Jan-Willem van der Veen, Peter Manza, Ehsan Shokri-Kojori, Danielle S. Kroll, Dana E. Feldman, Katherine L. McPherson, Catherine L. Biesecker, Rui Zhang, et al.

    Individuals with alcohol use disorder (AUD) show elevated brain metabolism of acetate at the expense of glucose. We hypothesized that a shift in energy substrates during withdrawal may contribute to withdrawal severity and neurotoxicity in AUD and that a ketogenic diet (KD) may mitigate these effects. We found that inpatients with AUD randomized to receive KD (n = 19) required fewer benzodiazepines during the first week of detoxification, in comparison to those receiving a standard American (SA) diet (n = 14). Over a 3-week treatment, KD compared to SA showed lower “wanting” and increased dorsal anterior cingulate cortex (dACC) reactivity to alcohol cues and altered dACC bioenergetics (i.e., elevated ketones and glutamate and lower neuroinflammatory markers). In a rat model of alcohol dependence, a history of KD reduced alcohol consumption. We provide clinical and preclinical evidence for beneficial effects of KD on managing alcohol withdrawal and on reducing alcohol drinking.